Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps.


Journal

Journal of the Royal Society of Medicine
ISSN: 1758-1095
Titre abrégé: J R Soc Med
Pays: England
ID NLM: 7802879

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 10 11 2020
pubmed: 11 11 2020
medline: 29 12 2020
Statut: ppublish

Résumé

In recent years there has been increasing awareness of problems that have undermined trust in medical research. This review outlines some of the most important issues including research culture, reporting biases, and statistical and methodological issues. It examines measures that have been instituted to address these problems and explores the success and limitations of these measures. The paper concludes by proposing three achievable actions which could be implemented to deliver significantly improved transparency and mitigation of bias. These measures are as follows: (1) mandatory registration of interests by those involved in research; (2) that journals support the 'registered reports' publication format; and (3) that comprehensive study documentation for all publicly funded research be made available on a World Health Organization research repository. We suggest that achieving such measures requires a broad-based campaign which mobilises public opinion. We invite readers to feedback on the proposed actions and to join us in calling for their implementation.

Identifiants

pubmed: 33167771
doi: 10.1177/0141076820956799
pmc: PMC7673265
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-443

Références

BMC Health Serv Res. 2018 Apr 2;18(1):236
pubmed: 29609611
BMJ. 2014 Feb 05;348:g1301
pubmed: 24500355
BMJ. 2020 Mar 11;368:m422
pubmed: 32161006
Trials. 2019 Feb 14;20(1):118
pubmed: 30760329
R Soc Open Sci. 2018 Jan 10;5(1):171511
pubmed: 29410855
BMJ. 2015 Dec 14;351:h6467
pubmed: 26668206
Trends Cogn Sci. 2019 Dec;23(12):983-985
pubmed: 31640917
J Gen Intern Med. 2019 Feb;34(2):176-178
pubmed: 30324292
PLoS One. 2016 May 16;11(5):e0155474
pubmed: 27183221
Nature. 2017 Oct 17;550(7676):303
pubmed: 29052636
BMJ. 2018 Apr 12;361:k1240
pubmed: 29650517
BMJ. 2018 Feb 13;360:k400
pubmed: 29440066
BMC Med Ethics. 2014 Aug 15;15:63
pubmed: 25128372
JAMA. 2010 May 26;303(20):2058-64
pubmed: 20501928
BMJ. 2018 Sep 12;362:k3218
pubmed: 30209058
N Engl J Med. 2008 Jan 17;358(3):252-60
pubmed: 18199864
PLoS Biol. 2020 Jul 16;18(7):e3000737
pubmed: 32673304
N Engl J Med. 1991 Oct 17;325(16):1180-3
pubmed: 1891034
Neurology. 2018 Jul 3;91(1):12-13
pubmed: 29884738
PLoS Med. 2005 Aug;2(8):e124
pubmed: 16060722
Ann Oncol. 2013 May;24(5):1238-44
pubmed: 23303339
Nat Hum Behav. 2018 Nov;2(11):793-796
pubmed: 31558810
PLoS Biol. 2018 Nov 20;16(11):e2006930
pubmed: 30457984
BMJ Evid Based Med. 2019 Oct 25;:
pubmed: 31653688
PLoS One. 2015 Jun 04;10(6):e0127362
pubmed: 26042410
Nature. 2016 Jul 27;535(7613):466
pubmed: 27466089
PLoS Biol. 2015 Mar 13;13(3):e1002106
pubmed: 25768323
BMJ. 2019 Nov 26;367:l6695
pubmed: 31771954
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
PLoS Biol. 2019 May 1;17(5):e3000246
pubmed: 31042704
J Clin Oncol. 2014 Dec 20;32(36):4120-6
pubmed: 25403215
BMJ. 1994 Jan 29;308(6924):283-4
pubmed: 8124111
PLoS One. 2016 Feb 26;11(2):e0149794
pubmed: 26919473
J Clin Epidemiol. 2016 Sep;77:44-51
pubmed: 27164274
BMJ Open. 2018 Mar 5;8(3):e019952
pubmed: 29581205
Int J Health Policy Manag. 2018 Mar 14;7(6):504-509
pubmed: 29935127
BMJ Open. 2017 Dec 14;7(12):e018647
pubmed: 29247106
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Psychol Sci. 2011 Nov;22(11):1359-66
pubmed: 22006061
BMJ. 2019 Nov 21;367:l6365
pubmed: 31753846
Pers Soc Psychol Rev. 1998;2(3):196-217
pubmed: 15647155
BMJ. 2018 Oct 30;363:k4582
pubmed: 30377163
PLoS Med. 2012;9(9):e1001308
pubmed: 22984354
JAMA. 1996 Aug 28;276(8):637-9
pubmed: 8773637
BMJ Evid Based Med. 2019 Nov 22;:
pubmed: 31757839
BMJ. 2003 May 31;326(7400):1167-70
pubmed: 12775614
JAMA. 2018 Apr 10;319(14):1429-1430
pubmed: 29566133
PLoS Med. 2015 Apr 14;12(4):e1001819
pubmed: 25874642
BMJ Open. 2019 May 9;9(5):e026589
pubmed: 31076472
Nature. 2017 Sep 12;549(7671):133
pubmed: 28905925
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2613-2619
pubmed: 29531025
BMC Med. 2015 Nov 18;13:282
pubmed: 26581191
F1000Res. 2016 Mar 03;5:272
pubmed: 26998238
Q J Exp Psychol (Hove). 2012;65(11):2271-9
pubmed: 22853650
Trials. 2018 Jan 29;19(1):80
pubmed: 29378640
JAMA. 2016 Mar 15;315(11):1141-8
pubmed: 26978209
JAMA Oncol. 2018 Oct 1;4(10):1426-1428
pubmed: 30178024
Trials. 2019 Feb 14;20(1):124
pubmed: 30760328
BMJ. 2019 Nov 6;367:l5896
pubmed: 31694810

Auteurs

Stephen H Bradley (SH)

Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9JT, UK.

Nicholas J DeVito (NJ)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.

Kelly E Lloyd (KE)

Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9JT, UK.

Georgia C Richards (GC)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.

Tanja Rombey (T)

Institute for Research in Operative Medicine, Witten/Herdecke University, Alfred-Herrhausen-Straûe 50, 58448 Witten, Germany.

Cole Wayant (C)

Centre for Health Sciences, Oklahoma State University, Tulsa 74107, USA.

Peter J Gill (PJ)

Department of Paediatrics, University of Toronto, Toronto M5G 1X8, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH